Journey Medical grants 300k RSUs to CEO, 150k RSUs to CFO

Journey Medical Corp

CEO Claude Maraoui received 300,000 RSUs; CFO Ernest De Paolantonio received 150,000 RSUs.
RSUs vest in four equal annual installments beginning on July 21, 2023.
Grants approved by Board on July 21, 2022 under the 2015 Stock Plan.
Unvested RSUs subject to forfeiture upon termination; full vesting upon Change of Control.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.